Literature DB >> 29541810

Nationwide study on the risk of unprovoked venous thromboembolism in non-traumatic osteonecrosis of femoral head.

Pei-Hsun Sung1, Hsin-Ju Chiang2,3, Yao-Hsu Yang4,5,6,7, John Y Chiang8,9, Chi-Jen Chen5, Hon-Kan Yip10,11,12,13, Mel S Lee14.   

Abstract

PURPOSE: Endothelial dysfunction is a risk factor for osteonecrosis of femoral head (ONFH) and venous thromboembolism (VTE) [defined as deep venous thrombosis (DVT) or pulmonary embolism (PE)]. However, the risk of unprovoked VTE in non-traumatic ONFH patients remains unclear.
METHODS: We investigated the relationship between ONFH and VTE using Taiwan National Health Insurance Research Database (NHIRD). Between 1997 and 2010, a total of 1514 non-traumatic ONFH patients were identified from 1,000,000 general populations after excluding initially concomitant diagnoses of DVT and PE, and subjects undergoing lower limb surgery within one year since enrollment. The comparison group (n = 15,140) without ONFH was set up by matching study cohort with age, gender, income and urbanization in a 1:10 ratio. Subjects diagnosed with VTE within one year after surgery were also excluded.
RESULTS: The patients with non-traumatic ONFH had significantly higher frequency of unprovoked VTE, including DVT, than general population (1.19 vs. 0.5%, p < 0.0007), whereas the frequency of PE was similar between these two groups (p = 0.4922). The cumulative incidence of VTE and DVT was also remarkably higher in the ONFH than non-ONFH group (all p < 0.001). After adjusting for age, gender, medications and comorbidities with multivariate analysis, the ONFH patients had a 2.3-fold increase in risk of DVT compared with non-ONFH counterparts (95% CI 1.28 to 4.13, p = 0.0053). Apart from ONFH, age > 65 years and hypertension were also identified as risk factors for DVT occurrence.
CONCLUSIONS: The incidence and risk of unprovoked VTE were significantly increased in the non-traumatic ONFH population.

Entities:  

Keywords:  Deep venous thrombosis (DVT); Endothelial dysfunction; Osteonecrosis of femoral head; Population-based cohort study; Venous thromboembolism (VTE)

Mesh:

Year:  2018        PMID: 29541810     DOI: 10.1007/s00264-018-3866-2

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  38 in total

Review 1.  Incidence of diagnosed deep vein thrombosis in the general population: systematic review.

Authors:  F J I Fowkes; J F Price; F G R Fowkes
Journal:  Eur J Vasc Endovasc Surg       Date:  2003-01       Impact factor: 7.069

2.  Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial.

Authors:  D W BARRITT; S C JORDAN
Journal:  Lancet       Date:  1960-06-18       Impact factor: 79.321

Review 3.  Non-steroidal anti-inflammatory drugs and risk of venous thromboembolism: a systematic review and meta-analysis.

Authors:  Patompong Ungprasert; Narat Srivali; Karn Wijarnpreecha; Prangthip Charoenpong; Eric L Knight
Journal:  Rheumatology (Oxford)       Date:  2014-09-24       Impact factor: 7.580

4.  Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study.

Authors:  Sigrun A Johannesdottir; Erzsébet Horváth-Puhó; Olaf M Dekkers; Suzanne C Cannegieter; Jens Otto L Jørgensen; Vera Ehrenstein; Jan P Vandenbroucke; Lars Pedersen; Henrik Toft Sørensen
Journal:  JAMA Intern Med       Date:  2013-05-13       Impact factor: 21.873

5.  Non-steroidal anti-inflammatory drug use and risk of venous thromboembolism.

Authors:  M Schmidt; C F Christiansen; E Horváth-Puhó; R J Glynn; K J Rothman; H T Sørensen
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

6.  Treatment for osteonecrosis of the femoral head: comparison of extracorporeal shock waves with core decompression and bone-grafting.

Authors:  Ching-Jen Wang; Feng-Sheng Wang; Chung-Cheng Huang; Kuender D Yang; Lin-Hsiu Weng; Hsuan-Ying Huang
Journal:  J Bone Joint Surg Am       Date:  2005-11       Impact factor: 5.284

7.  Investigation of alcohol metabolizing enzyme genes in Chinese alcoholics with avascular necrosis of hip joint, pancreatitis and cirrhosis of the liver.

Authors:  You-Chen Chao; Shyu-Jye Wang; Heng-Cheng Chu; Wei-Kuo Chang; Tsai-Yuan Hsieh
Journal:  Alcohol Alcohol       Date:  2003 Sep-Oct       Impact factor: 2.826

Review 8.  Osteonecrosis: current perspectives on pathogenesis and treatment.

Authors:  C C Chang; A Greenspan; M E Gershwin
Journal:  Semin Arthritis Rheum       Date:  1993-08       Impact factor: 5.532

Review 9.  Osteonecrosis in the foot.

Authors:  Christopher W DiGiovanni; Amar Patel; Ryan Calfee; Florian Nickisch
Journal:  J Am Acad Orthop Surg       Date:  2007-04       Impact factor: 3.020

Review 10.  Evidence for using alendronate to treat adult avascular necrosis of the femoral head: a systematic review.

Authors:  Ru-Bin Luo; Tiao Lin; Hui-Ming Zhong; Shi-Gui Yan; Jian-An Wang
Journal:  Med Sci Monit       Date:  2014-11-26
View more
  5 in total

1.  Six thousand papers already: "the outcome of a matter is better than its beginning…".

Authors:  Marius M Scarlat; Marko Pećina
Journal:  Int Orthop       Date:  2018-05       Impact factor: 3.075

2.  Stem cell therapy in bilateral osteonecrosis: computer-assisted surgery versus conventional fluoroscopic technique on the contralateral side.

Authors:  Philippe Hernigou; Benjamin Thiebaut; Victor Housset; Claire Bastard; Yasuhiro Homma; Younes Chaib; Charles Henri Flouzat Lachaniette
Journal:  Int Orthop       Date:  2018-04-26       Impact factor: 3.075

3.  Risk of Venous Thromboembolic Events in Patients with Osteonecrosis of the Femoral Head Undergoing Primary Hip Arthroplasty.

Authors:  Pei-Hsun Sung; Yao-Hsu Yang; Hsin-Ju Chiang; John Y Chiang; Hon-Kan Yip; Mel S Lee
Journal:  J Clin Med       Date:  2019-12-06       Impact factor: 4.241

4.  lncRNA FGD5-AS1 Regulates Bone Marrow Stem Cell Proliferation and Apoptosis by Affecting miR-296-5p/STAT3 Axis in Steroid-Induced Osteonecrosis of the Femoral Head.

Authors:  Yadi Wu; Lun Fang; Yong Gao; Zhiqiu Zhao; Lu Zhou; Gang Zhang
Journal:  J Healthc Eng       Date:  2022-02-12       Impact factor: 2.682

5.  Association of Nitric Oxide Synthase Polymorphism and Coagulopathy in Patients with Osteonecrosis of the Femoral Head.

Authors:  Cheng-Ta Wu; Rio L C Lin; Pei-Hsun Sung; Feng-Chih Kuo; Hon-Kan Yip; Mel S Lee
Journal:  J Clin Med       Date:  2022-08-24       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.